AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22017917
Drug: 2.5 g
RxNorm normalized name: Vaporizer 2.5 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g granular PGX®
Trial: 22017917
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g granular PGX®
Trial: 22017917
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g (inert fibre)
Trial: 3938266
Drug: Cibenzoline (65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cibenzoline (65 mg gelules, four times daily)
Trial: 3938266
Drug: Quinidine arabo-galactane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine arabo-galactane sulfate (QAGS, 206 mg gelules, four times daily)
Trial: 21284407
Drug: BMV 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMV 0.1% cream
Trial: 9334595
Drug: Atropine sulfate
RxNorm normalized name: Atropine Sulfate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulfate (0.075 mg) combined with papaverine hydrochloride (50 mg), prostaglandin E1 (10 micrograms), and phentolamine mesylate (0.2 mg)
Trial: 9334595
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of papaverine hydrochloride (50 mg), prostaglandin E1 (10 micrograms), and phentolamine mesylate (0.2 mg) without atropine sulfate
Trial: 8466313
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 24 IU for 5 days
Trial: 27930531
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (1 mg/kg bolus, 60 μg/kg/h continuous infusion)
Trial: 20968198
Drug: Cerebrolysin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (50 mL i.v. per day for 10 days)
Trial: 12208031
Drug: 5-aminolaevulinic acid-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-aminolaevulinic acid-induced photodynamic therapy (ALA-PDT)
Trial: 8737704
Drug: Subconjunctival methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subconjunctival methylprednisolone hemisuccinate (MH) 40 mg in 0.5 cc
Trial: 7757308
Drug: Nimodipine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (30 mg t.i.d.)
Trial: 6994782
Drug: Guanfacine (3-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (3-4 mg daily)
Trial: 6994782
Drug: Clonidine (0.3-0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.3-0.45 mg daily)
Trial: 30264164
Drug: Bacillus coagulans
RxNorm normalized name: Bacillus coagulans
DrugBank: Bacillus coagulans (DB19246)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus coagulans LBSC [2 billion/g]
Trial: 23358470
Drug: Lenalidomide 25
RxNorm normalized name: lenalidomide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 25 mg PO (days 1-21) and gemcitabine 1,000 mg/m² IV (days 1, 8, and 15) each 28-day cycle
Trial: 21316768
Drug: Short-term therapies
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term therapies
Trial: 19584651
Drug: Low-dose recombinant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose recombinant tissue plasminogen activator (rt-PA) 50 mg with concomitant intravenous heparinization
Trial: 10078083
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg ibutilide
Trial: 10078083
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg ibutilide
Trial: 10078083
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg DL-sotalol
Trial: 2514457
Drug: Two puffs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two puffs of a mixture of 1 mg disodium cromoglycate and 0.5 mg of reproterol hydrochloride administered by metered dose inhaler through Volumatic spacer
Trial: 2514457
Drug: Two puffs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two puffs of a mixture of 1 mg disodium cromoglycate and 0.5 mg of reproterol hydrochloride administered by metered dose inhaler through Nebuhaler spacer
Trial: 2514457
Drug: Two puffs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two puffs of a mixture of 1 mg disodium cromoglycate and 0.5 mg of reproterol hydrochloride administered by metered dose inhaler through InspirEase spacer
Trial: 2514457
Drug: Two puffs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two puffs of a mixture of 1 mg disodium cromoglycate and 0.5 mg of reproterol hydrochloride administered by metered dose inhaler through Synchron‐Aerosol spacer
Trial: 30047216
Drug: Liraglutide, Dulaglutide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide, Dulaglutide, Exenatide extended-release
Trial: 28329368
Drug: Daily TMP-SMX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily TMP-SMX plus monthly dihydroartemisinin-piperaquine (DP)
Trial: 28329368
Drug: Daily TMP-SMX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily TMP-SMX alone
Trial: 7201809
Drug: Niludipine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niludipine (60 or 120 mg daily for five consecutive weeks, with an initial dose of 20 mg three times on the first day)
Trial: 7201809
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered for one week after the drug period)
Trial: 7201809
Drug: Niludipine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niludipine (single dose study)
Trial: 25899566
Drug: Sphenopalatine ganglion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sphenopalatine ganglion stimulation with one acupuncture needle for 4 weeks (once or twice weekly, total four to eight sessions)
Trial: 25899566
Drug: Individualized verum
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized verum acupuncture for 4 weeks (twice weekly, total eight sessions)
Trial: 23016126
Drug: Pre-exercise hyperhydration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-exercise hyperhydration (PEH) with 26 mL/kg bodyweight of a 130 mmol/L sodium solution
Trial: 19095343
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg micronised 17beta‐oestradiol plus 5 mg dydrogesterone (E/D group; n=18)
Trial: 19095343
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated equine oestrogens plus 5 mg medroxyprogesterone acetate (CEE/MPA group; n=14)
Trial: 19095343
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control group; n=16)
Trial: 9503255
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg +/- pindolol
Trial: 9503255
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg +/- pindolol and 10 mg ipsapirone
Trial: 7709763
Drug: Intranasal salmon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal salmon calcitonin (100 U on alternate days) + oral calcium (1500 mg daily)
Trial: 3108346
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (intracoronary streptokinase)
Trial: 29605108
Drug: Routine MRI
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine MRI preparation (appointment letter)
Trial: 22129475
Drug: Intensive blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive blood pressure lowering treatment (Systolic BP≤140mmHg within 1 hour)
Trial: 22129475
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment strategy (target systolic BP of 180mmHg)
Trial: 14975534
Drug: Biventricular pacing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biventricular pacing (cardiac resynchronisation therapy or CRT)
Trial: 7919941
Drug: Haloperidol doses
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol doses of 40-45 mg/day
Trial: 7919941
Drug: Haloperidol doses
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol doses of 60-80 mg/day
Trial: 7919941
Drug: Haloperidol doses
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol doses greater than 100 mg/day
Trial: 28566028
Drug: Forensic Assertive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forensic Assertive Community Treatment (FACT)
Trial: 28832365
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment arm (SBP < 120 mmHg)
Trial: 28832365
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment arm (SBP < 140 mmHg)
Trial: 23567785
Drug: Subglottic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subglottic and gastric treatment suspension (polymyxin E 100 mg, vancomycin 1 g, and amphotericin B 500 mg) + intravenous cefotaxime (1 g 3 times a day for 4 days)
Trial: 23567785
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + intravenous cefotaxime (1 g 3 times a day for 4 days)
Trial: 23567785
Drug: Subglottic placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subglottic placebo and gastric treatment suspension + intravenous cefotaxime (1 g 3 times a day for 4 days)
Trial: 23567785
Drug: Subglottic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subglottic treatment suspension and gastric placebo + intravenous cefotaxime (1 g 3 times a day for 4 days)
Trial: 15006014
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone (CRO) 20 mg
Trial: 11491366
Drug: FSH/human menopausal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSH/human menopausal gonadotropin combination
Trial: 8148352
Drug: Baseline diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline diet (36% kcal as fat: 15% saturated, 15% monounsaturated, and 6% polyunsaturated fat; 180 mg cholesterol.1000 kcal‐1)
Trial: 31715584
Drug: Postexercise glucose-fructose
RxNorm normalized name: fructose / glucose / phosphoric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postexercise glucose-fructose coingestion (1.5 g·kg‐1·hr‐1 carbohydrate)
Trial: 31715584
Drug: Postexercise glucose-fructose
RxNorm normalized name: fructose / glucose / phosphoric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postexercise glucose-fructose coingestion (1.2 g·kg‐1·hr‐1 carbohydrate)
Trial: 21561959
Drug: Modafinil (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (up to 200 mg/day for 8 weeks)
Trial: 12595969
Drug: Steroid+ (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid+ (10 mg/day, n=17)
Trial: 12595969
Drug: Steroid- (n=10)
RxNorm normalized name: 4-amino-N(10)-methylpteroylglutamic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid- (n=10)
Trial: 9069450
Drug: Gemfibrozil (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (300 to 900 mg/day)
Trial: 29846686
Drug: No drug-eluting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug-eluting sheet (control) group
Trial: 24862977
Drug: PM(2.5) increase
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PM(2.5) increase (7.0 µg/m³)
Trial: 19423029
Drug: Debridement plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debridement plus topical antifungal nail lacquer
Trial: 17374661
Drug: Egg treatment
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egg treatment (640 mg/d additional cholesterol and 600 µg/d additional lutein + zeaxanthin)
Trial: 17374661
Drug: Baseline treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline treatment (no additional cholesterol or lutein + zeaxanthin)
Trial: 11476766
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (40 mg/d, p.o.)
Trial: 9916606
Drug: Cefprozil 500
RxNorm normalized name: cefprozil 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefprozil 500 mg BID
Trial: 9916606
Drug: Amoxicillin/clavulanate 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 500 mg/125 mg TID
Trial: 3054453
Drug: VP-16 plus
RxNorm normalized name: etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: VP-16 plus lower dose adriamycin (VAD)
Trial: 31733813
Drug: Structured six-session
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured six-session psychological treatment
Trial: 31733813
Drug: Routine antenatal
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine antenatal health care and three monthly phone calls
Trial: 28710902
Drug: Single-session cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-session cognitive behavioural therapy intervention including a risk communication module
Trial: 25789661
Drug: Idarucizumab (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idarucizumab (doses between 20 mg and 8 g as a 1-hour intravenous infusion, or 1, 2 or 4 g as a 5-minute infusion)
Trial: 19470877
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with Aml/Val/HCTZ 10/320/25 mg
Trial: 19470877
Drug: Dual therapies
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapies (Val/HCTZ 320/25 mg, Aml/Val 10/320 mg, Aml/HCTZ 10/25 mg)
Trial: 17407632
Drug: Intensive multi-injection
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive multi-injection protocol (two or four times daily regular/NPH insulin injections)
Trial: 17407632
Drug: Four times
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four times daily insulin injections
Trial: 15379417
Drug: Leptin/adiponectin (L/A)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leptin/adiponectin (L/A) ratio in obese children
Trial: 15379417
Drug: Leptin/adiponectin (L/A)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leptin/adiponectin (L/A) ratio in non-obese children
Trial: 15204127
Drug: Multiple-choice task
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-choice task where participants selected possibilities indicating truth or falsity of compound verbal propositions.
Trial: 7377911
Drug: Amitriptyline once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline once daily
Trial: 7377911
Drug: Amitriptyline three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline three times daily
Trial: 27621158
Drug: Advice to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advice to take daily probiotics (from October 2013 to March 2014)
Trial: 27621158
Drug: Advice to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advice to take daily probiotics
Trial: 20077490
Drug: Separate algorithm
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate algorithm for neo‐adjuvant chemotherapy‐treated tissues
Trial: 12010236
Drug: Intracavernosal injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernosal injection therapy without sexological counselling (‐SC)
Trial: 12010236
Drug: Intracavernosal injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernosal injection therapy with sexological counselling (+SC)
Trial: 21434485
Drug: Ethanolic extract
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanolic extract of Ruta Chalepensis L. (250 microg/ml)
Trial: 11203735
Drug: 0.025% capsaicin
RxNorm normalized name: CAPSAICIN 2.5 mg in 10 g TOPICAL PATCH [0.025% Capsaicin Patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025% capsaicin cream applied 4 times daily for 4 weeks
Trial: 11203735
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle cream) applied 4 times daily for 4 weeks
Trial: 18230389
Drug: Clobetasol 0.05%
RxNorm normalized name: CLOBETASOL 0.05% EMOLLIENT TOP CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobetasol 0.05% ointment
Trial: 8624625
Drug: Tenoxicam 20
RxNorm normalized name: tenoxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam 20 mg once daily
Trial: 1458892
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral contraceptive containing 0.15 mg LNG and 0.03 mg EE2 (Microgynon)
Trial: 1458892
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral contraceptive (Microgynon)
Trial: 1458892
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose administration of the same formulation
Trial: 2935811
Drug: Prednisone-azathioprine-low dose
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prednisone-azathioprine-low dose cyclosporin A (8 mg/kg)
Trial: 3422792
Drug: Bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine plus diflunisal (500 mg)
Trial: 3422792
Drug: Lidocaine plus
RxNorm normalized name: Icy Hot Lidocaine Plus Menthol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine plus diflunisal (500 mg)
Trial: 28646527
Drug: Dentalvibe® (DV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentalvibe® (DV) - buccal and palatal infiltration on the maxilla and inferior alveolar nerve block (IANB) with vibration
Trial: 28646527
Drug: Traditional method
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional method (TR) - same injections without vibration
Trial: 20350952
Drug: ASA 500
RxNorm normalized name: ASA 500 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 500 mg/PSE 30 mg
Trial: 20350952
Drug: ASA 1000
RxNorm normalized name: Canasa 1000mg Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 1000 mg/PSE 60 mg
Trial: 20350952
Drug: APAP 1000
RxNorm normalized name: APAP 1000 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APAP 1000 mg/PSE 60 mg
Trial: 18245404
Drug: Atomoxetine (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (1.2 mg/kg per day)
Trial: 1949926
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) dosing
Trial: 6547808
Drug: Cookies with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cookies with 20 g of Fusarium graminearium
Trial: 6547808
Drug: Cupcakes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cupcakes with 10 g of Paecilomyces variotii
Trial: 31732062
Drug: Yacon syrup
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yacon syrup (40g, 14g of FOS)
Trial: 29653651
Drug: 6F sheath/guide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6F sheath/guide combination
Trial: 20642768
Drug: alpha-bisabolol-containing cream
RxNorm normalized name: alpha-bisabolol, (+-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-bisabolol-containing cream applied once a day for 8 weeks
Trial: 20642768
Drug: vehicle control
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vehicle control cream
Trial: 15791171
Drug: Methohexital alone
RxNorm normalized name: Methohexital
DrugBank: Methohexital (DB00474)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methohexital alone (80-100 mg IV bolus)
Trial: 15791171
Drug: Remifentanil (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (500 mcg IV bolus) with low-dose methohexital (40 mg IV)
Trial: 9198431
Drug: IAN block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IAN block + IO injection (2% lidocaine with 1:100,000 epinephrine)
Trial: 9198431
Drug: IAN block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IAN block (mock IO injection)
Trial: 9198431
Drug: IO injection
RxNorm normalized name: Io-Shield
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IO injection
Trial: 1761896
Drug: Rokitamycin (RKM)
RxNorm normalized name: rokitamycin
DrugBank: Rokitamycin (DB13409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rokitamycin (RKM) 600 mg daily for 5 days
Trial: 1761896
Drug: Ofloxacin (OFLX)
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin (OFLX) 600 mg daily for 5 days